Heidi Sankala
- Molecular Biology top 5%
- Cell Biology top 2%
- Physiology
- Cancer Research top 10%
- Immunology
- Co-authors
- Sheldon MilstienSarah SpiegelMichael MaceykaNitai C. HaitRachelle E. TomanPaul R. GravesHervé Le StunffHong Liu
- Topics
- Histone Deacetylase Inhibitors Research (9 papers)Protein Degradation and Inhibitors (7 papers)Sphingolipid Metabolism and Signaling (6 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Heidi Sankala
28 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Biology 1.6k
- Cell Biology 604
- Physiology 179
- Cancer Research 176
- Immunology 173
Countries citing papers authored by Heidi Sankala
This map shows the geographic impact of Heidi Sankala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Sankala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Sankala more than expected).
Fields of papers citing papers by Heidi Sankala
This network shows the impact of papers produced by Heidi Sankala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Sankala. The network helps show where Heidi Sankala may publish in the future.
Co-authorship network of co-authors of Heidi Sankala
This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Sankala. A scholar is included among the top collaborators of Heidi Sankala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Sankala. Heidi Sankala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 3 | |
| 3 | 26 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 30 | |
| 7 | 49 | |
| 8 | 9 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | 14 | |
| 12 | 175 | |
| 13 | 132 | |
| 14 | 1 | |
| 15 | 177 | |
| 16 | SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolismbreakdown → | 530 |
| 17 | 52 | |
| 18 | 309 | |
| 19 | 88 | |
| 20 | The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. | 38 |
About Heidi Sankala
Heidi Sankala is a scholar working on Hematology, Genetics and Molecular Biology, having authored 28 papers that have together received 1.7k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (9 papers), Protein Degradation and Inhibitors (7 papers) and Sphingolipid Metabolism and Signaling (6 papers). The work is most often cited by research in Cell Biology (604 citations), Molecular Biology (1.6k citations) and Cancer Research (176 citations). Heidi Sankala has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Sheldon Milstien, Sarah Spiegel, Michael Maceyka, Nitai C. Hait, Rachelle E. Toman, Paul R. Graves, Hervé Le Stunff, Hong Liu, Min Zhang and Leslie S. Satin. Their work appears in journals such as Journal of Biological Chemistry, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.